BLGO vs. VOXR, AREC, ASM, NB, GAMC, TRX, HYMC, LOOP, USGO, and NMG
Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Vox Royalty (VOXR), American Resources (AREC), Avino Silver & Gold Mines (ASM), NioCorp Developments (NB), Golden Arrow Merger (GAMC), TRX Gold (TRX), Hycroft Mining (HYMC), Loop Industries (LOOP), U.S. GoldMining (USGO), and Nouveau Monde Graphite (NMG).
BioLargo (NASDAQ:BLGO) and Vox Royalty (NASDAQ:VOXR) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, community ranking, profitability and media sentiment.
In the previous week, Vox Royalty had 14 more articles in the media than BioLargo. MarketBeat recorded 17 mentions for Vox Royalty and 3 mentions for BioLargo. BioLargo's average media sentiment score of 0.69 beat Vox Royalty's score of 0.68 indicating that BioLargo is being referred to more favorably in the media.
BioLargo has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Vox Royalty has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.
Vox Royalty has a consensus price target of $3.00, indicating a potential upside of 40.19%. Given Vox Royalty's higher probable upside, analysts clearly believe Vox Royalty is more favorable than BioLargo.
BioLargo has higher earnings, but lower revenue than Vox Royalty. BioLargo is trading at a lower price-to-earnings ratio than Vox Royalty, indicating that it is currently the more affordable of the two stocks.
BioLargo received 109 more outperform votes than Vox Royalty when rated by MarketBeat users. Likewise, 60.99% of users gave BioLargo an outperform vote while only 50.00% of users gave Vox Royalty an outperform vote.
Vox Royalty has a net margin of 2.93% compared to BioLargo's net margin of 0.00%. Vox Royalty's return on equity of 2.76% beat BioLargo's return on equity.
0.0% of BioLargo shares are held by institutional investors. Comparatively, 46.0% of Vox Royalty shares are held by institutional investors. 19.0% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Vox Royalty beats BioLargo on 11 of the 15 factors compared between the two stocks.
Get BioLargo News Delivered to You Automatically
Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioLargo Competitors List
Related Companies and Tools
